Atossa Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -14.9% | -14.9% | -14.6% |
| FY2022 | -22.9% | -22.9% | -21.8% |
| FY2023 | -33.1% | -33.1% | -31.3% |
| FY2024 | -35.7% | -35.7% | -33.4% |
| FY2025 | -88.4% | -88.4% | -73.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -14.9% | -14.9% | -14.6% |
| FY2022 | -22.9% | -22.9% | -21.8% |
| FY2023 | -33.1% | -33.1% | -31.3% |
| FY2024 | -35.7% | -35.7% | -33.4% |
| FY2025 | -88.4% | -88.4% | -73.0% |